This OPC interview discusses the growing importance of molecular testing, care coordination, and oral oncology therapies in optimizing outcomes for patients with gastrointestinal malignancies.
Nick Capote, PharmD, MS, BCSCP
Advertisement
Articles by Nick Capote, PharmD, MS, BCSCP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
3
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
4
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
5